# Neal Mody

> Neal Mody is a seed investor at Endless Frontier Labs backing Biotechnology and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Endless Frontier Labs](https://shizune.co/investors/profile/endless-frontier-labs)
- Location: Bellevue, United States
- Total investments: 3
- Last investment: Feb 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/nealmody

Neal Mody is a seed investor at Endless Frontier Labs in Bellevue focused on Biotechnology and Health Care. I’m obsessed with building great companies and focus on those life sciences that will affect humanity.Early in my career, I was fortunate enough to help scale Ambature, a materials science company in the field of superconductivity. When I started Ambature, I didn’t have any experience in materials science; nevertheless, I operated under thebelief that the inventor’s idea was right. Fast forward a few years, by the time I left my role, we created over 200 patents with more than 3,700 unique claims, accounting for more than half patents in the field of superconductivity.After I left Ambature, I wanted to make a more significant impact in life sciences, and ultimately on humanity. Being driven by this social mission, I thought about starting a few companies simultaneously; however, after some back and forth, I ultimately concluded that starting a fund would better allow me to scale my efforts.Through Zoic Capital, my team and I help our portfolio companies and investors: ► Develop large scale inclusive IP development strategy ► Help connect and codevelop deals with potential strategic acquirersWe are currently the only US-based venture firm focused solely on investing in the seed stage of Medtech, we go through a rigorous vetting process with each investment opportunity to ensure that: 1. their technological developments represent at least a 10X improvement in the standard of care 2. their technology relies upon scientific mechanisms which are fully supported by published literature, independent trials, and personal observation 3. in most cases, they have unique hardware and IP coupled with unique software 4. the leadership team has the necessary combination of vision and experience to create a transformational company 5. has an initial regulatory approval on a short timeline, typically two to four yearsIf you want to learn more about Zoic, the types of companies we invest in, or if you’d like to talk about the market and feature on my podcast, feel free to get in touch with me via email: neal@zoiccapital.comIf you know of an interesting deal for Zoic to look at, feel free to get in touch with my team here: deals@zoiccapital.com

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Health Care | 2 | 67% |
| Medical | 1 | 33% |
| Robotics | 1 | 33% |
| Software | 1 | 33% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Convertible Note | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| Canada | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HDT Bio | HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology. The company's technology platforms and products cover a wide range of immunotherapy modalities and mechanisms of action, including innate immunity activation, adaptive immune response amplification, and tumor-tight junction disruption. Its mission isto maintain the rapid and significant progress made in the fight against the world's deadliest infectious diseases by developing cutting-edge immunotherapy technologies in a cost-effective manner across leading markets as well as low or middle-income countries. | $3M | Seed | Feb 16, 2021 |  |
| BioROSA Technologies | BioROSA Technologies creates a biologically-based diagnostic standard of care for Autism Spectrum Disorders. The company was founded in 2018 and is based in Belmont, Massachusetts. |  | Convertible Note | Jul 02, 2020 |  |
| ODS Medical | ODS Medical Inc. is a medical device company that seeks to commercialize their exclusive Raman spectroscopy system for real-time detection of tissue abnormalities through the development, manufacture and sales of products for a range of clinical settings.ODS Medical Inc. is dedicated to bringing to the hands of physicians the next generation ofdiagnostic tools. Building on our revolutionary proprietary platform technology, we integrate cutting edge optical probes with the most sophisticated software, based on machine learning algorithms, to empower doctors to make critical decisions- in real-time - with unprecedented sensitivity, specificity and accuracy. |  | Seed | Jun 01, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 2 deals together
- [MEDTEQ+](https://shizune.co/investors/profile/medteq) — VC Fund, 1 deal together
- [SGInnovate](https://shizune.co/investors/profile/sginnovate) — VC Fund, 1 deal together

## About Endless Frontier Labs

VC Fund · New York, United States

The Endless Frontier Labs provides a mentorship program to accelerate the success of early-stage startups.

5 contacts available at Endless Frontier Labs.

| Name | Title | Profile |
| --- | --- | --- |
| Christian Theriault | Mentor - Deep-Tech, Life Sciences, & Strategy | https://shizune.co/investors/profile/christian-theriault |
| Daniel Darling | Mentor (Deep Tech & Digital) | https://shizune.co/investors/profile/daniel-darling |
| Jun Deng | Mentor | https://shizune.co/investors/profile/jun-deng |
| Maggie Sprenger | Mentor | https://shizune.co/investors/profile/maggie-sprenger |
| Neal Mody | Mentor | https://shizune.co/investors/profile/neal-mody |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Neal Mody invest in?

Neal Mody invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Convertible Note stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Neal Mody last invest?

The most recent investment recorded for Neal Mody closed in Feb 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co